Information gained from linking SEER cancer registry data to state-level hospital discharge abstracts

被引:27
作者
Brooks, JM
Chrischilles, E
Scott, S
Ritho, J
Chen-Hardee, S
机构
[1] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA
关键词
breast cancer; linkages; SEER; comorbidities; insurance; inpatient discharges;
D O I
10.1097/00005650-200011000-00007
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES. Our goal was to link patients from the Iowa Surveillance, Epidemiology, and End Results (SEER) Registry to their respective inpatient discharge abstracts from an Iowa Health Care Cost and Utilization Project (HCUP)-formatted database and evaluate whether this linkage provides information related to cancer treatment variation. METHODS. Computer algorithms linked patients from the Iowa SEER Registry to discharge abstracts using 5 variables consistently defined between the databases (hospital identification, date of birth, admission date, discharge date, and zip code). Abstracts were reviewed for validity, and links not passing face validity were excluded., SUBJECTS. Our sample contained 7,296 patients with early-stage breast cancer (I, IIa, IIb) with surgery from the Iowa SEER Registry from 1989 through 1994 with contacts only with Iowa hospitals. RESULTS. Inpatient discharges abstracts were linked to 86.4% of the patients in our sample. More than 96% of the linked discharges for Medicare patients had a corresponding Medicare claim. Over 45% of the linked patients were not covered by Medicare. Comorbidity indexes were comparable to other published sources. Significant differences in diagnosis, comorbidities, and treatment were found across third-party payers. CONCLUSIONS. This linkage provides a valuable source of comorbidity and insurance data and perhaps the only source of secondary clinical information for the uninsured. This linkage is best suited for cancers requiring inpatient stays for treatment and for those states where border crossing for treatment is low.
引用
收藏
页码:1131 / 1140
页数:10
相关论文
共 23 条
  • [11] 2-1
  • [12] Lazovich DA, 1999, CANCER-AM CANCER SOC, V86, P628, DOI 10.1002/(SICI)1097-0142(19990815)86:4<628::AID-CNCR11>3.0.CO
  • [13] 2-L
  • [14] National Cancer Institute, SURV EP END RES
  • [15] Minimal increase in use of breast-conserving surgery from 1986 to 1990
    Nattinger, AB
    Gottlieb, MS
    Hoffman, RG
    Walker, AP
    Goodwin, JS
    [J]. MEDICAL CARE, 1996, 34 (05) : 479 - 489
  • [16] Lumpectomy or mastectomy? Is breast conserving surgery too expensive?
    Norum, J
    Olsen, JA
    Wist, EA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1997, 45 (01) : 7 - 14
  • [17] Potosky AL, 1999, HEALTH SERV RES, V34, P525
  • [18] Breast cancer survival and treatment in health maintenance organization and fee-for-service settings
    Potosky, AL
    Merrill, RM
    Riley, GF
    Taplin, SH
    Barlow, W
    Fireman, BH
    BallardBarbash, R
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22): : 1683 - 1691
  • [19] POTOSKY AL, 1993, MED CARE, V31, P732
  • [20] Stage at diagnosis and treatment patterns among older women with breast cancer - An HMO and fee-for-service comparison
    Riley, GF
    Potosky, AL
    Klabunde, CN
    Warren, JL
    Ballard-Barbash, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (08): : 720 - 726